Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)

Affiliations

¹ Princess Margaret Cancer Centre, University Health Network, Toronto, ON;
² Medical Oncology, Southern Alberta Cancer Research Institute, Alberta Health Services, Calgary, AB;
³ Division of Medical Oncology, Queen Elizabeth II Heath Sciences Centre, Halifax, NS;
⁴ Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre; and The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON;
⁵ Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB;
⁶ Division of Medical Oncology, Cancer Care Manitoba, University of Manitoba, Winnipeg, MB;
⁷ Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Research Institute, Toronto, ON;
⁸ Division of Oncology, Lakeridge Health Centre, Toronto, ON;
⁹ Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, ON;
¹⁰ Alberta Health Services, AB;
¹¹ Hematology and Medical Oncology Service, Department of Medicine, Centre Hospitalier de l'Universite de Montreal, Montreal, Montreal, QC;
¹² Department of Surgery, Dalhousie University, Halifax, NS;
¹³ BC Cancer Agency Sindi Ahluwalia Hawkins Centre for the Southern Interior, Kelowna, BC.

Suzanne Richter et al. Can Urol Assoc J. 2013 Nov-Dec.

. 2013 Nov-Dec;7(11-12):E797-811.

doi: 10.5489/cuaj.1794.

¹ Princess Margaret Cancer Centre, University Health Network, Toronto, ON;
² Medical Oncology, Southern Alberta Cancer Research Institute, Alberta Health Services, Calgary, AB;
³ Division of Medical Oncology, Queen Elizabeth II Heath Sciences Centre, Halifax, NS;
⁴ Department of Medicine, Division of Medical Oncology, The Ottawa Hospital Cancer Centre; and The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON;
⁵ Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB;
⁶ Division of Medical Oncology, Cancer Care Manitoba, University of Manitoba, Winnipeg, MB;
⁷ Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Research Institute, Toronto, ON;
⁸ Division of Oncology, Lakeridge Health Centre, Toronto, ON;
⁹ Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, ON;
¹⁰ Alberta Health Services, AB;
¹¹ Hematology and Medical Oncology Service, Department of Medicine, Centre Hospitalier de l'Universite de Montreal, Montreal, Montreal, QC;
¹² Department of Surgery, Dalhousie University, Halifax, NS;
¹³ BC Cancer Agency Sindi Ahluwalia Hawkins Centre for the Southern Interior, Kelowna, BC.

No abstract available

Figures

1. Barnholtz-Sloan JS, Maldonado JL, Pow-Sang J, et al. Incidence trends in primary malignant penile cancer. Urol Oncol. 2007;25:361–7. doi: 10.1016/j.urolonc.2006.08.029. - DOI - PubMed
1. Canadian Cancer Society’s Steering Committee on Cancer Statistics . Canadian Cancer Statistics. Toronto, ON: Canadian Cancer Society; 2011. 2011.
1. American Cancer Society . Cancer Facts and Figures 2011. Atlanta, Ga: American Cancer Society; 2011.
1. Pompao ACL, Heyns C, Abrams P. International Consultation on Penile Cancer. 2009.
1. Pizzocaro G, Algaba F, Horenblas S, et al. EAU penile cancer guidelines 2009. Eur Urol. 2010;57:1002–12. doi: 10.1016/j.eururo.2010.01.039. - DOI - PubMed